Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel (ALCOOTAX)

Institut Curie

Status: Completed

Conditions: Tumors

Treatments: Other: blood sampling

Study type: Interventional

Funder types: Other

Identifiers

NCT01448759

IC 2011-03

Details and patient eligibility

About

The purpose of this study is to evaluate plasma alcohol concentration in patients receiving Paclitaxel or Docetaxel infusion.

Full description

In this study, there is no experimental treatment, or experimental care.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chemotherapy with docetaxel or paclitaxel on an every 3-week schedule.
• Patient with bitherapy are eligible only if the taxane is the first infusion.
• All type of tumor.
• Age>18 years old.
• Signed written informed consent.

Exclusion criteria

• Patient under 18.
• Patient with bitherapy, if docetaxel or paclitaxel is not administered first.
• Patient deprived of liberty.